NA
NAGE

NewEdge Advisors’s Niagen Bioscience NAGE Stock Holding History

NewEdge Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,779
Closed -$126K – 4446
2025
Q4 		$126K Sell
19,779
-2,206
-10% -$15.3K ﹤0.01% 2696
2025
Q3 		$205K Buy
21,985
+2,261
+11% +$22.8K ﹤0.01% 2403
2025
Q2 		$284K Sell
19,724
-8,012
-29% -$79.1K ﹤0.01% 2050
2025
Q1 		$191K Buy
27,736
+25,563
+1,176% +$161K ﹤0.01% 2110
2024
Q4 		$11.5K Sell
2,173
-11,196
-84% -$61.3K ﹤0.01% 2991
2024
Q3 		$48.8K Buy
+13,369
New +$42.1K ﹤0.01% 2440
2024
Q2 		– Sell
-21,415
Closed -$74.5K – 4039
2024
Q1 		$74.5K Buy
+21,415
New +$39.6K ﹤0.01% 2162

Other funds holding NAGE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.8B AUM 48.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return